Panaroma Central Station Product Usage: This device can view real time, store, print, graph, and trend patient clinical and demographic data. The device can also set independent alarm limits for data send by the bedside monitor.

Recall Insight

This FDA Devices action (record #Z-1156-2014) was formally reported on March 19, 2014, with the manufacturer initiating the action on January 8, 2014. It is classified under Moderate severity (Class II), with a current status of Terminated. Mindray DS USA, Inc. dba Mindray North America is listed as the recalling firm, operating out of Mahwah, NJ. Federal records indicate 732 units in the US units are affected.

The documented reason for this recall is: Mindray has identified two issues with the Panorama Central Station. Full Disclosure data may lag behind the Panorama system time clock when the Panorama Central Station is in use with Mindray¿s V-Series Monitor. Addi… Distribution data in the federal record shows the product reached: Worldwide Distribution - USA Nationwide Distribution. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 6 were also issued by FDA Devices. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 12 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.